VPS33B

VPS33B late endosome and lysosome associated

Basic information

Region (hg38): 15:90998673-91022603

Links

ENSG00000184056NCBI:26276OMIM:608552HGNC:12712Uniprot:Q9H267AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • arthrogryposis, renal dysfunction, and cholestasis 1 (Definitive), mode of inheritance: AR
  • arthrogryposis-renal dysfunction-cholestasis syndrome (Supportive), mode of inheritance: AR
  • arthrogryposis, renal dysfunction, and cholestasis 1 (Strong), mode of inheritance: AR
  • arthrogryposis, renal dysfunction, and cholestasis 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12; Arthrogryposis, renal dysfunction, and cholestasis 1ARAudiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; RenalIndividuals with Keratoderma-ichthyosis-deafness syndrome, autosomal recessive have been described with hearing impairment, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Cholestasis, progressive familial intrahepatic has been described as involving early-onset hepatic dysfunction, and medical and surgical interventions have been described as beneficial in some individuals; Individuals with Arthrogryposis, renal dysfunction, and cholestasis 1 may have manifstations including hearing loss, cardiovascular anomalies, renal dysfunction, and cholestasis, and awareness may allow early diagnosis and medical or surgical management of these sequelaeAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Renal28017832; 30561130; 31479177

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the VPS33B gene.

  • not provided (15 variants)
  • Arthrogryposis, renal dysfunction, and cholestasis 1 (11 variants)
  • VPS33B-related disorder (1 variants)
  • Cholestasis, progressive familial intrahepatic, 12 (1 variants)
  • Keratoderma-ichthyosis-deafness syndrome, autosomal recessive (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS33B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
40
clinvar
6
clinvar
52
missense
1
clinvar
116
clinvar
2
clinvar
1
clinvar
120
nonsense
10
clinvar
1
clinvar
11
start loss
0
frameshift
5
clinvar
3
clinvar
8
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
3
clinvar
7
splice region
1
2
9
13
1
26
non coding
14
clinvar
77
clinvar
60
clinvar
151
Total 19 9 136 119 67

Highest pathogenic variant AF is 0.0000461

Variants in VPS33B

This is a list of pathogenic ClinVar variants found in the VPS33B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-90998713-A-C Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Jan 12, 2018)317416
15-90998714-A-T Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Apr 27, 2017)884571
15-90998820-T-C Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Jan 12, 2018)317417
15-90998850-G-A Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Jan 12, 2018)317418
15-90998862-C-T Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Jan 13, 2018)885502
15-90998965-G-A Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain significance (Jan 12, 2018)885503
15-90998978-G-A Uncertain significance (Aug 15, 2017)593697
15-90998988-TC-AG Uncertain significance (Apr 07, 2022)1923363
15-90999009-C-T Inborn genetic diseases Uncertain significance (Apr 15, 2024)3332240
15-90999013-C-T VPS33B-related disorder Uncertain significance (Oct 04, 2023)2632088
15-90999014-G-A Likely benign (Jun 28, 2017)781722
15-90999015-C-T Inborn genetic diseases Uncertain significance (Jun 07, 2023)2559048
15-90999023-G-T Likely benign (Feb 28, 2018)738177
15-90999032-C-T Likely benign (Jun 27, 2023)2876775
15-90999033-G-A Inborn genetic diseases Uncertain significance (Aug 15, 2023)1810479
15-90999047-C-T Likely benign (Jul 17, 2023)2983364
15-90999049-T-C Arthrogryposis, renal dysfunction, and cholestasis 1 • not specified Conflicting classifications of pathogenicity (Feb 14, 2023)1028605
15-90999061-A-G Likely benign (Jun 23, 2023)722711
15-90999068-T-C Arthrogryposis, renal dysfunction, and cholestasis 1 Conflicting classifications of pathogenicity (Sep 01, 2023)885504
15-90999107-C-T Benign (Nov 12, 2018)1288168
15-90999183-G-GC Likely benign (Jan 13, 2021)1706786
15-90999188-GC-G Likely benign (Jan 13, 2021)1194057
15-90999251-GT-G Benign (Nov 12, 2018)1245281
15-90999286-A-G Benign (Jul 31, 2019)1226832
15-90999318-GT-G Benign (Sep 04, 2019)1289946

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
VPS33Bprotein_codingprotein_codingENST00000333371 2324188
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.41e-160.5821256530951257480.000378
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3643143330.9440.00002054057
Missense in Polyphen99113.10.875331287
Synonymous0.3201201250.9640.000006961149
Loss of Function1.763143.50.7120.00000282477

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007920.000792
Ashkenazi Jewish0.0007940.000794
East Asian0.0004890.000489
Finnish0.000.00
European (Non-Finnish)0.0003870.000387
Middle Eastern0.0004890.000489
South Asian0.0002010.000196
Other0.0006520.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in vesicle-mediated protein trafficking to lysosomal compartments and in membrane docking/fusion reactions of late endosomes/lysosomes. Mediates phagolysosomal fusion in macrophages (PubMed:18474358). Proposed to be involved in endosomal maturation implicating VIPAS39. In epithelial cells, the VPS33B:VIPAS39 complex may play a role in the apical recycling pathway and in the maintenance of the apical-basolateral polarity (PubMed:20190753). Seems to be involved in the sorting of specific cargos from the trans-Golgi network to alpha-granule-destined multivesicular bodies (MVBs) promoting MVBs maturation in megakaryocytes (By similarity). {ECO:0000250|UniProtKB:P59016, ECO:0000269|PubMed:18474358, ECO:0000305|PubMed:20190753, ECO:0000305|PubMed:23918659}.;
Disease
DISEASE: Arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) [MIM:208085]: A multisystem disorder, characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity. Platelet dysfunction is common. {ECO:0000269|PubMed:15052268, ECO:0000269|PubMed:18853461, ECO:0000269|PubMed:20190753, ECO:0000269|PubMed:22753090, ECO:0000269|PubMed:23918659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.118

Intolerance Scores

loftool
0.822
rvis_EVS
-0.53
rvis_percentile_EVS
20.82

Haploinsufficiency Scores

pHI
0.0591
hipred
Y
hipred_score
0.516
ghis
0.554

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.789

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Vps33b
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
vps33b
Affected structure
enterocyte
Phenotype tag
abnormal
Phenotype quality
dilated

Gene ontology

Biological process
vesicle docking involved in exocytosis;endosome organization;endosome to lysosome transport;protein transport;vesicle-mediated transport;peptidyl-lysine hydroxylation;melanosome localization;lysosome localization;collagen metabolic process;membrane fusion;platelet alpha granule organization;autophagosome maturation
Cellular component
cytoplasm;lysosome;lysosomal membrane;late endosome;Golgi apparatus;AP-3 adaptor complex;clathrin-coated vesicle;HOPS complex;platelet alpha granule;early endosome membrane;late endosome membrane;perinuclear region of cytoplasm;recycling endosome;clathrin complex
Molecular function
protein binding